Eiger Gets Deal With Merck Over $46M Rare-Disease Drug Sale
By Alex Wittenberg · May 1, 2024, 7:21 PM EDT
Bankrupt Eiger BioPharmaceuticals Inc. told a Texas federal judge Wednesday it had struck a tentative agreement with drug company Merck & Co. over licensing rights to a rare-disease drug that it...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login